Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly K Scarsi

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
The Lancet. HIV|June 5, 2020
Chasing the cabotegravir tail: implications for preventionKimberly K Scarsi
Journal of the International Association of Providers of AIDS Care|April 27, 2021
The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?Kimberly K Scarsi, Susan Swindells
Current Opinion in HIV and AIDS|December 6, 2021
A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIVSara H Bares, Kimberly K Scarsi
The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia|March 29, 2003
The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differencesKimberly K Scarsi, Michael J Postelnick
Expert Opinion on Pharmacotherapy|April 27, 2025
A review of pharmacokinetic data describing long-acting injectable cabotegravir during pregnancyShawnalyn W Sunagawa, Kimberly K Scarsi
British Journal of Clinical Pharmacology|June 1, 2024
Moving forward to 'put people first'Alice Tseng, Kimberly K Scarsi, Mona Loutfy
JAMA|February 13, 2025
Regulation of Controlled Substances and Reproductive HealthJulia Tasset, Kimberly K Scarsi, Alison Edelman
Obstetrics and Gynecology Clinics of North America|February 23, 2023
Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in PregnancyKristina M Brooks, Kimberly K Scarsi, Mark Mirochnick
Clinical Pharmacokinetics|June 19, 2016
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer InhibitorsAnthony T Podany, Kimberly K Scarsi, Courtney V Fletcher
Advances in Therapy|March 6, 2010
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIVChad J Achenbach, Kimberly K Scarsi, Robert L Murphy
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
The Lancet. HIV|June 5, 2020
Chasing the cabotegravir tail: implications for preventionKimberly K Scarsi
Journal of the International Association of Providers of AIDS Care|April 27, 2021
The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?Kimberly K Scarsi, Susan Swindells
Current Opinion in HIV and AIDS|December 6, 2021
A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIVSara H Bares, Kimberly K Scarsi
The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia|March 29, 2003
The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differencesKimberly K Scarsi, Michael J Postelnick
Expert Opinion on Pharmacotherapy|April 27, 2025
A review of pharmacokinetic data describing long-acting injectable cabotegravir during pregnancyShawnalyn W Sunagawa, Kimberly K Scarsi
British Journal of Clinical Pharmacology|June 1, 2024
Moving forward to 'put people first'Alice Tseng, Kimberly K Scarsi, Mona Loutfy
JAMA|February 13, 2025
Regulation of Controlled Substances and Reproductive HealthJulia Tasset, Kimberly K Scarsi, Alison Edelman
Obstetrics and Gynecology Clinics of North America|February 23, 2023
Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in PregnancyKristina M Brooks, Kimberly K Scarsi, Mark Mirochnick
Clinical Pharmacokinetics|June 19, 2016
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer InhibitorsAnthony T Podany, Kimberly K Scarsi, Courtney V Fletcher
Advances in Therapy|March 6, 2010
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIVChad J Achenbach, Kimberly K Scarsi, Robert L Murphy
Pageof 10